1Ping Z H,Nguyen Q T,Neel J.Investigations of poly(vinyl alcohol) /poly (N-vinyl-2-pyrrolidione) blends,1.Compatibility[J].Die Makromoleculare Chemie,1989,190(2):437-448.
2Razzak M T,Erizal Z,Dewi S P,et al.The characterization of dressing component materials and radiation formation of PVA-PVP hydrogel[J].Radiat.Phys.Chem,1999,55:153-165.
3Aqil M,Ali A.Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate:in vitro characterization[J].Eur.J.Pharm.Biopharm,2002,54:161-164.
4Amnuaikit C,Ikeuchi I,Ogawara K,et al.Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use[J].Int.J.Pharm,2005,289:167 -178.
5Mukherjee B,Mahapatra S,Gupta R,et al.A comparison between povidone -ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation[J].Eur.J.Pharm.Biopharm,2005,59:475-483.
6Akimoto T,Kawahara K.Polymeric transdermal drug penetration enhancer,the enhancing effect of oligodimethylsiloxane containing a glueopyranosyl end group[J].J Control Release,2001,77:49.
7Akimoto T,Nagase Y.Novel transdermal drug penetration enhancer:synthesis and enhancing effect of alkyldisiloxane compounds containing glucopyranosyl group[J].Controlled Release,2003,88 (2):243-252.
8Akimoto T,Aoyagi T,Minoshima J,et al.Polymeric percutaneous drug penetration enhancer Synthesis and enhancing property of PEG/PDMS block copolymer with a cationic end group[J].J Controlled Release,1997,49:229-224.
9Chauhan A S,Sridevi S,Chalasani K B,et al.Dendrimermediated transdermal delivery:enhanced bioavailability of indomethacin[J].J Control Release,2003,90:335.
10Cui Z R,Mumper R J.Chitosan -based nanopartieles for topical genetic immunization[J].J Control Release,2001,75:409.
